Neratinib in the Early-Stage/Extended Adjuvant Breast Cancer Patient: Q&A

被引:0
作者
O'Shaughnessy, Joyce A.
O'Regan, Ruth
Isaacs, Claudine
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:16 / 17
页数:2
相关论文
共 50 条
[41]   Recent advances in adjuvant systemic therapy for early-stage breast cancer [J].
Bedard, P. L. ;
Cardoso, F. .
ANNALS OF ONCOLOGY, 2008, 19 :122-127
[42]   Selection of optimal adjuvant endocrine therapy for early-stage breast cancer [J].
Al-Hajj A. ;
O'Regan R. .
Current Treatment Options in Oncology, 2006, 7 (2) :153-165
[43]   Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer [J].
Del Mastro, Lucia .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) :1137-+
[44]   Quality of life and adjuvant system therapy for early-stage breast cancer [J].
Grimison, Peter S. ;
Stockler, Martin R. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (08) :1123-1134
[45]   Association between treatment duration and overall survival in early-stage HER2+breast cancer patients receiving extended adjuvant therapy with neratinib in the ExteNET trial. [J].
Moy, Beverly ;
Takahashi, Masato ;
Ohtani, Shoichiro ;
Chmielowska, Ewa ;
Yamamoto, Naohito ;
Coudert, Bruno P. ;
Xu, Feng ;
Wong, Alvin F. ;
Chan, Arlene .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[46]   Optimal exposure to docetaxel in adjuvant chemotherapy for early-stage breast cancer [J].
Guo, Jujiang ;
Lin, Weijie ;
Weng, Yiyin ;
Chen, Yao ;
Zeng, Shaowu ;
Lin, Juli ;
Zheng, Xiuluan ;
Li, Xiuqing ;
Lin, Min ;
Yu, Xuefen ;
Chen, Quanyao .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) :2205-2213
[47]   Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer [J].
Reyes, Sylvia A. ;
King, Tari A. ;
Fei, Kezhen ;
Franco, Rebeca ;
Bickell, Nina A. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) :1537-1542
[48]   Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer [J].
F. Rosenbaek ;
H. S. Holm ;
J. v. B. Hjelmborg ;
M. Ewertz ;
Jeanette Dupont Jensen .
Supportive Care in Cancer, 2020, 28 :3763-3769
[49]   How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer [J].
Michael Untch ;
Miguel Martin ;
Michelino De Laurentiis ;
Joseph Gligorov .
Oncology and Therapy, 2021, 9 :297-309
[50]   Current and future directions for adjuvant chemotherapy in early-stage breast cancer [J].
Ellis, P .
EJC SUPPLEMENTS, 2006, 4 (04) :14-20